The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.

@article{Mcguigan2009TheAO,
  title={The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.},
  author={Christopher Mcguigan and Felice Daverio and Isabel Nájera and Joseph A. Martin and Klaus Klumpp and David Bernard Smith},
  journal={Bioorganic \& medicinal chemistry letters},
  year={2009},
  volume={19 11},
  pages={
          3122-4
        }
}
Synthesis of Novel Nucleoside Analogue Phosphorothioamidate Prodrugs and in vitro Anticancer Evaluation Against RKO Human Colon Carcinoma Cells
TLDR
Novel phosphorothioamidates of pyrimidine nucleoside analogues have been prepared and evaluated in vitro against RKO human colon cancer cell by the MTT cytotoxicity assay, with a 10-fold enhancement in anticancer activity.
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
TLDR
In this review, the seminal contribution of Chris McGuigan’s research to this field is presented and his technology proved to be extremely successful in drug discovery and has led to two Food and Drug Administration-approved antiviral agents.
Nucleoside Analogues: Synthesis and Biological Properties of Azanucleoside Derivatives
The azanucleosides are nucleoside analogues where the furanose ring is replaced by a nitrogen-containing ring or chain. Many azanucleosides are potent antiviral, anticancer and antimicrobial agents,
Thiophene-expanded guanosine analogues of Gemcitabine.
An overview of ProTide technology and its implications to drug discovery
TLDR
The ProTide approach has been extremely successful in delivering blockbuster antiviral medicines and it seems promising in oncology, but its application to non-nucleoside-based small molecules is recently emerging and proving effective in other therapeutic areas.
Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
TLDR
The development of the phosphoramidate technology, mechanism of action and the application of the technology to various monophosphorylated nucleosides and sugars will be reviewed.
Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
TLDR
For many decades, the design of new nucleoside analogs as potential therapeutic agents focused on both sugar and nucleobase modifications, but now nucleosides triphosphates cannot be considered as viable drug candidates as they usually have poor chemical stability along with high polarity that hinders them from transporting across cell membranes.
An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies
TLDR
This review summarizes current efforts with inhibitors targeting the HCV RdRp and how the various inhibitors affect the mechanism of RNA synthesis.
Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5'-monophosphates bearing a biodegradable protecting group.
TLDR
The kinetics of the deprotection of these pro-drugs by porcine liver esterase and by a whole cell extract of human prostate carcinoma was studied by HPLC-ESI-MS/MS.
Tuning the Stereoselectivity in One‐Pot Scission/Addition Processes: Synthesis of Azanucleotide Analogues from Proline Derivatives
TLDR
The one-pot preparation of azanucleotide analogues from proline derivatives has been achieved by a sequential radical decarboxylation/phosphorylation process, giving high yields of the nucleotide analogs.
...
1
2
3
...

References

SHOWING 1-10 OF 15 REFERENCES
Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
TLDR
Results confirm that phosphoramidate ProTides can deliver monophosphates of ribonucleoside analogues and suggest a potential path to the generation of novel antiviral agents against HCV infection.
First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
TLDR
Phosphoramidates achieved a significant improvement in antiviral potency over the parent nucleoside 4'-azidoadenosine with no increase in cytotoxicity.
Synthesis, Anti-Human Immunodeficiency Virus Activity and Esterase Lability of Some Novel Carboxylic Ester-Modified Phosphoramidate Derivatives of Stavudine (d4T)
TLDR
No clear positive correlation emerged in the design, synthesis and antiviral evaluation of a series of lipophilic, masked phosphoramidate derivatives of the anti-human immunodeficiency virus (HIV) nucleoside analogue d4T, indicating that, at least within this series, factors other than simple esterase lability may be the major determinants of antiviral potency.
Aryloxy phosphoramidate triesters as pro-tides.
TLDR
The development of aryloxy phosphoramidate triesters as an effective pro-tide motif for the intracellular delivery of charged bio-active antiviral nucleoside monophosphates is described.
Prodrug approaches of nucleotides and oligonucleotides.
TLDR
The purpose of the present review is to summarize the current knowledge on the chemical aspects of alternative prodrug strategies at nucleotide and oligonucleotide level.
Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides
TLDR
This review will discuss the major advances and future directions of the emerging field of antiviral and anticancer pronucleotide design and development.
Enzymatically activated cycloSal-d4T-monophosphates: The third generation of cycloSal-pronucleotides.
TLDR
The third generation of cycloSal-pronucleotides, 5-diacetoxymethyl-cyclo Sal-d4T-monophosphates (5-di-AM-cycloside monophosphate) is reported as a new class of "lock-in"-modified cyclo saligenyl unit, and antiviral activities against HIV are presented.
Ring opening of 4',5'-epoxynucleosides: a novel stereoselective entry to 4'-C-branched nucleosides.
Stereoselective synthesis of 4'-alpha-carbon-substituted nucleosides has been accomplished through epoxidation of 4',5'-unsaturated nucleosides with dimethyldioxirane (DMDO) and successive
...
1
2
...